Dobutamine in severe scorpion envenomation: Effects on standard hemodynamics, right ventricular performance, and tissue oxygenation

Chest

Volumn 116, Issue 3, 1999, Pages 748-753

  Elatrous, Souheil ^a   Nouira, Semir ^a   Besbes Ouanes, Lamia ^a   Boussarsar, Mohamed ^a   Boukef, Riadh ^a   Marghli, Soudani ^a   Abroug, Fekri ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

Dobutamine; Heart failure; Scorpion envenomation

Indexed keywords

DOBUTAMINE; HYDROCORTISONE SODIUM SUCCINATE; VENOM ANTISERUM;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOSE RESPONSE; ENVENOMATION; FEMALE; HEART INDEX; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART STROKE VOLUME; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE VOLUME; HUMAN; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; LUNG ARTERY PRESSURE; LUNG EDEMA; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; SCORPION; THERMODILUTION; TISSUE OXYGENATION; TREATMENT OUTCOME;

EID: 0032858155     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.3.748     Document Type: Article

References (29)

1. 1 Goyffon M, Vachon M, Broglio N. Epidemiological and clinical characteristics of the scorpion envenomation in Tunisia. Toxicon 1982; 20:337-344
2. 2 Gueron M, Ilia R, Sofer S. The cardiovascular system after scorpion envenomation: a review. J Toxicol Clin Toxicol 1992; 30:245-258
3. 3 Gueron M, Adolph RJ, Grupp H., et al. Hemodynamic and myocardial consequences of scorpion venom. Am J Cardiol 1980; 45:979-986
4. 4 Abroug F, Boujdria A, Belghith M, et al. Cardiac dysfunction and pulmonary edema following scorpion envenomation. Chest 1991; 100:1057-1059
5. 5 Abroug F, Ayari M, Nouira S, et al. Assessment of left ventricular function in severe scorpion envenomation: combined hemodynamic and echo-Doppler study. Intensive Care Med 1995; 21:629-635
6. 6 Tarasiuk A, Sofer S, Huberfelo S, et al. Hemodynamic effects following injection of venom from the scorpion Leirus quinquestriatus. J Crit Care 1994; 9:134-140
7. 7 Margulis M, Sofer S, Zalstein E, et al. Abnormal coronary perfusion in experimental scorpion envenomation. Toxicon 1994; 32:1675-1678
8. 8 Abroug F, Nouira S, Boujdaria R, et al. Cardiac dysfunction and pulmonary edema following scorpion envenomation [letter]. Chest 1992; 102:1308-1309.
9. 9 Nouira S, Abroug F, Haguiga H, et al. Right ventricular dysfunction following severe scorpion envenomation. Chest 1995; 108:682-687
10. 10 Karnad DR. Hemodynamic patterns in patients with scorpion envenomation. Heart 1998; 79:485-489
11. 11 Rahav G, Weiss AT. Scorpion sting-induced pulmonary edema: scintigraphic evidence of cardiac dysfunction. Chest 1990; 97:1478-1480
12. 12 Gueron M, Margulis G, Ilia R, et al. The management of scorpion envenomation 1993 [letter]. Toxicon 1993; 31:1071-1083
13. 13 Gateau T, Bloom M, Clark R. Response to specific Centruroides sculpturatus antivenom in 151 cases of scorpion stings. J Toxicol Clin Toxicol 1994; 32:165-171
14. 14 Dehesa-Davila M, Possani LD. Scorpionism and serotherapy in Mexico. Toxicon 1994; 32:1015-1088
15. 15 Freire-Maia L, Campos JA, Amaral CF. Approaches to the treatment of scorpion envenoming. Toxicon 1994; 32:1009-1014
16. 16 Ismail M. The treatment of the scorpion envenoming syndrome: the Saudi experience with serotherapy. Toxicon 1994; 32:1009-1014
17. 17 Sofer S, Shahak E, Gueron M. Scorpion envenomation and antivenom therapv. J Pediatr 1994; 124:973-978.
18. 18 Bawaskar HS, Bawaskar PH. Treatment of cardiovascular manifestations of human scorpion envenoming: is serotherapy essential? J Trop Med Hyg 1991; 94:156-158
19. 19 Legall JR, Loirat P, Alperovitch A, et al. A simplified acute physiology score for ICU patients. Crit Care Med 1984; 12:975-977
20. 20 Tarasiuk A, Khvatskin S, Sofer S. Effects of antivenom serotherapy on hemodynamic pathophysiology in dogs injected with L. quinquestriatus scorpion venom. Toxicon 1998; 36:963-971
21. 21 Sofer S, Cohen R, Shapir Y, et al. Scorpion venom leads to gastrointestinal ischemia despite increased oxygen delivery in pigs. Crit Care Med 1997; 25:834-840
22. 22 Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure): guidelines for the evaluation and management of heart failure. Circulation 1995; 92:2764-2784
23. 23 Fessler HE. Heart-lung interactions: applications in the critically ill. Eur Respir J 1997; 10:226-237
24. 24 Vatner SF, McRitchie RJ, Braunwald E. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs. J Clin Invest 1974; 53:1265-1273
25. 25 Renard M, Bernard R. Clinical and hemodynamic effects of dobutamine in acute myocardial infarction with left heart failure. J Cardiovasc Pharmacol 1980; 2:543-552
26. 26 Keung EC, Siskind SJ, Sonnenblick EH, et al. Dobutamine therapy in acute myocardial infarction. JAMA 1981; 245:144-146
27. 27 Lichtwarck-Aschoff M, Beale R, Pfeiffer UJ. Central venous pressure, pulmonary artery occlusion pressure, intrathoracic blood volume, and right ventricular end-diastolic volume as indicators of cardiac preload. J Crit Care 1996; 11:180-188
28. 28 Robotham JL, Takata M, Bermau M. Ejection fraction revisited. Anesthesiology 1991; 74:172-183
29. 29 Shibutami K, Komatsu T, Kubal K, et al. Critical level of oxygen delivery in anaesthesized man. Crit Care Med 1983; 11:640-643